3 weeks ago

Gland Pharma, Neuland Laboratories announce long-term CDMO partnership

Gland Pharma, Neuland Laboratories announce long-term CDMO partnership
Gland Pharma signs pact with Neuland Labs · thehansindia.com

Two medicine-making companies in India decided to become partners.

One company is called Gland Pharma, and it is known for making sterile medicines.

The other company is called Neuland Laboratories, and it is very good at making complex medicine ingredients, called APIs.

Under the new partnership, Gland Pharma will build a special sterile manufacturing suite to produce some of these ingredients.

The ingredients will be used for microparticle depot products, which are medicines that release their effect slowly over time.

By working together, the two companies can serve customers all over the world.

Their leaders said the partnership combines the best skills of both companies.

They believe it will bring high quality, reliability, and a steady supply of medicines.

This is good news for companies that make and use these medicines.

Key facts

Companies involved
Gland Pharma Limited and Neuland Laboratories Limited
Partnership type
Long-term strategic CDMO partnership
Gland Pharma's commitment
Establish a sterile manufacturing suite for APIs pertaining to microparticle depot products
Neuland's expertise
Complex API development and manufacturing
Gland Pharma's expertise
Global sterile manufacturing and regulatory compliance track record
Gland Pharma executive
Srinivas Sadu, Executive Chairman
Neuland executive
Saharsh Davuluri, CEO

Quotes

Saharsh Davuluri

CEO, Neuland Laboratories

“Through this partnership with Gland Pharma, we are combining Neuland’s expertise in complex APIs with Gland’s proven sterile manufacturing capabilities to create a differentiated platform for global customers. Together, we are strengthening our ability to deliver the quality, reliability, and supply assurance that innovators and generic companies expect from their CDMO partners.”
thehansindia.com
“By leveraging the complementary strengths of both organizations, we will provide a robust and scalable CDMO solution backed by world‑class quality, compliance and manufacturing excellence. We believe this partnership creates a strong foundation for sustainable growth and long‑term value creation for our customers and both organizations.”
thehansindia.com

Sources

Related news